石四药集团（02005.HK）今日盘中大涨5.28%，股价表现强劲。这一显著涨幅与公司主要股东的增持行为密切相关。
根据港交所最新权益披露资料显示，石四药集团执行董事、主席兼行政总裁曲继广于3月31日在二级市场增持了280万股公司股票。此次增持的平均价格为每股3.1911港元，涉资约893.51万港元。增持后，曲继广的持股数量增至1,149,226,000股，持股比例从38.81%上升至38.90%。
市场分析人士指出，公司高管增持通常被视为对公司未来发展前景持乐观态度的信号。曲继广作为公司的核心管理人员，此次大手笔增持无疑增强了投资者对石四药集团的信心。这也解释了为何公司股价在消息公布后出现如此明显的上涨。投资者普遍认为，这一举动表明公司内部对其业务发展和未来增长潜力持积极看法，从而刺激了市场的买入热情。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.